摘要:
The present invention relates to improved models for progressive epithelial neoplasias and methods for their use. In particular, the invention provides transgenic mice comprising a human papilloma virus early region oncogene operably linked to a promoter which directs expression of the oncogene in a transient amplifying cell in the mice.
摘要:
The present invention provides a conjugate that contains a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of pre-malignant dysplastic skin and which includes the amino acid sequence SRPRR (SEQ ID NO: 1) or a conservative variant or peptidomimetic thereof. The present invention further provides a conjugate containing a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of malignant skin and which includes the amino acid sequence CGKRK (SEQ ID NO: 6) or the amino acid sequence CDTRL (SEQ ID NO: 7), or a conservative variant or peptidomimetic of one of these sequences.
摘要翻译:本发明提供了一种缀合物,其包含与归巢肽或肽模拟物连接的治疗部分,其选择性地置于恶变前皮肤的脉管系统中,并且包括氨基酸序列SRPRR(SEQ ID NO:1)或保守变体或肽模拟物 其中。 本发明还提供了一种缀合物,其含有连接到归巢肽或肽模拟物的治疗部分,其选择性地置于恶性皮肤脉管系统中,其包括氨基酸序列CGKRK(SEQ ID NO:6)或氨基酸序列CDTRL(SEQ ID NO: NO:7),或这些序列之一的保守变体或肽模拟物。
摘要:
The invention provides a conjugate that includes a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to vasculature of premalignant pancreas. The peptide or peptidomimetic contains at least 5 contiguous amino acids of an amino acid sequence selected from CRSRKG (SEQ ID NO:9) and CEYQLDVE (SEQ ID NO:34), or a conservative variant or peptidomimetic thereof. The invention additionally provides a conjugate containing a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to pancreatic tumor cells and pancreatic tumor vasculature, the peptide or peptidomimetic comprising at least 5 contiguous amino acids of an amino acid sequence selected from CKAAKNK (SEQ ID NO:15), CKGAKAR (SEQ ID NO:19), and VGVGEWSV (SEQ ID NO:35), or a conservative variant or peptidomimetic thereof.
摘要翻译:本发明提供了一种缀合物,其包括与肽或肽模拟物连接的治疗部分,其选择性地归属于恶化前胰腺的脉管系统。 肽或肽模拟物含有选自CRSRKG(SEQ ID NO:9)和CEYQLDVE(SEQ ID NO:34)的氨基酸序列的至少5个连续氨基酸,或其保守变体或肽模拟物。 本发明另外提供了一种缀合物,其含有与肽或肽模拟物连接的治疗部分,其选择性地置于胰腺肿瘤细胞和胰腺肿瘤血管系统中,所述肽或肽模拟物包含选自以下的氨基酸序列的至少5个连续氨基酸:SEQ ID NO: NO:15),CKGAKAR(SEQ ID NO:19)和VGVGEWSV(SEQ ID NO:35),或其保守变体或肽模拟物。
摘要:
The present invention provides a conjugate that contains a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of pre-malignant dysplastic skin and which includes the amino acid sequence SRPRR (SEQ ID NO: 1) or a conservative variant or peptidomimetic thereof. The present invention further provides a conjugate containing a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of malignant skin and which includes the amino acid sequence CGKRK (SEQ ID NO: 6) or the amino acid sequence CDTRL (SEQ ID NO: 7), or a conservative variant or peptidomimetic of one of these sequences.
摘要:
The invention provides a conjugate that includes a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to vasculature of premalignant pancreas. The peptide or peptidomimetic contains at least 5 contiguous amino acids of an amino acid sequence selected from CRSRKG (SEQ ID NO:9) and CEYQLDVE (SEQ ID NO:34), or a conservative variant or peptidomimetic thereof. The invention additionally provides a conjugate containing a therapeutic moiety linked to a peptide or peptidomimetic that selectively homes to pancreatic tumor cells and pancreatic tumor vasculature, the peptide or peptidomimetic comprising at least 5 contiguous amino acids of an amino acid sequence selected from CKAAKNK (SEQ ID NO:15), CKGAKAR (SEQ ID NO:19), and VGVGEWSV (SEQ ID NO:35), or a conservative variant or peptidomimetic thereof.
摘要翻译:本发明提供了一种缀合物,其包括与肽或肽模拟物连接的治疗部分,其选择性地归属于恶化前胰腺的脉管系统。 肽或肽模拟物含有选自CRSRKG(SEQ ID NO:9)和CEYQLDVE(SEQ ID NO:34)的氨基酸序列的至少5个连续氨基酸,或其保守变体或肽模拟物。 本发明另外提供了一种缀合物,其含有与肽或肽模拟物连接的治疗部分,其选择性地置于胰腺肿瘤细胞和胰腺肿瘤血管系统中,所述肽或肽模拟物包含选自以下的氨基酸序列的至少5个连续氨基酸:SEQ ID NO: NO:15),CKGAKAR(SEQ ID NO:19)和VGVGEWSV(SEQ ID NO:35),或其保守变体或肽模拟物。
摘要:
This invention provides methods employing prefoldin-4 (PFDN-4) nucleic acid and polypeptide sequences to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and/or for prognostic applications. Further, the invention provides methods of identifying inhibitors of PfDN-4 and methods of treating cancer by inhibiting the expression and/or activity of PFDN-4.